4//SEC Filing
Duey Marc 4
Accession 0001104659-23-095017
CIK 0001781983other
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 9:50 PM ET
Size
26.2 KB
Accession
0001104659-23-095017
Insider Transaction Report
Form 4
Duey Marc
Director
Transactions
- Conversion
Series A Non-Voting Convertible Preferred Stock
2022-08-23−1,161→ 0 total(indirect: By Spouse)Exercise: $0.00→ Common Stock (11,610 underlying) - Conversion
Series A Non-Voting Convertible Preferred Stock
2022-08-23−400,969→ 0 totalExercise: $0.00→ Common Stock (4,009,690 underlying) - Conversion
Common Stock
2022-08-23+4,009,690→ 4,167,589 total - Award
Stock Options (Right to Buy)
2023-08-23+2,000→ 2,000 totalExercise: $3.65Exp: 2033-08-23→ Common Stock (2,000 underlying) - Award
Common Stock
2023-08-23+500→ 208,878 total - Conversion
Common Stock
2022-08-23+11,610→ 602 total(indirect: By Spouse)
Footnotes (5)
- [F1]These shares represent restricted stock units which were granted on August 23, 2023, and which will vest and be settled in common stock on August 23, 2024, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
- [F2]Reflects a one-for-20 reverse split, effective as of 5:00 p.m. Eastern Time on February 10, 2023
- [F3]The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, or for any other purpose.
- [F4]Following stockholder approval at the Issuer's annual stockholder's meeting, each share of Series A Non-Voting Convertible Preferred Stock is convertible into 10 shares of the Issuer's common stock ("Common Stock") at any time at the option of the holder thereof, subject to certain limitations, including that a holder of Series A Non-Voting Convertible Preferred Stock is prohibited from converting shares of Series A Non-Voting Convertible Preferred Stock into shares of Common Stock if, as a result of such conversion, such holder, together with its affiliates, would beneficially own more than a specified percentage (to be established by the holder between 4.9% and 19.9%) of the total number of shares of Common Stock issued and outstanding immediately after giving effect to such conversion. The Series A Non-Voting Convertible Preferred Stock has no expiration date.
- [F5]The option vests in full on August 23, 2024, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001925150
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 9:50 PM ET
- Size
- 26.2 KB